Intelligent BIO Solutions Inc. revenue
Intelligent BIO Solutions Inc.'s revenue was $4.2m in fiscal 2026, up 38.1% on the year before. Since fiscal 2020 ($188,744) it has grown at a compound 67.8% a year.
Revenue history
| Fiscal year | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 189 | 1,980 | 437 | 1,257 | 3,112 | 3,053 | 4,215 |
| Growth on the year before | — | +949.3% | −77.9% | +187.5% | +147.6% | −1.9% | +38.1% |
| Gross profit | — | — | — | 327 | 1,426 | 1,247 | 2,050 |
| Gross margin | — | — | — | 26.0% | 45.8% | 40.8% | 48.6% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Sales of Goods Cartidges | $2.5M | 59.0% | ▲ 41.1% |
| Sales of Goods Readers | $902,263 | 21.4% | ▲ 26.8% |
| Other Sales Accessories | $827,349 | 19.6% | ▲ 43.0% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United Kingdom | $4.2M | 98.5% | ▲ 44.8% |
| Other Country | $40,199 | 1.0% | ▼ 69.7% |
| Asia Pacific | $12,467 | 0.3% | ▼ 57.3% |
| Americas | $8,750 | 0.2% | ▼ 61.3% |
From Intelligent BIO Solutions Inc.'s 10-K filed August 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Intelligent BIO Solutions Inc. | $4.2m | 38.1% | 39.0% |
| Cerenome, Inc. | $4.2m | -21.0% | 16.1% |
| Biomerica Inc | $4.3m | -11.2% | -7.1% |
| Charming Medical Ltd | $4.8m | -22.7% | — |
| Icecure Medical Ltd. | $3.4m | 2.7% | — |
| Neuraxis, Inc | $5.3m | 65.2% | 25.6% |
Compare with peers
- Cerenome, Inc. revenue
- Biomerica Inc revenue
- Charming Medical Ltd revenue
- Icecure Medical Ltd. revenue
- Neuraxis, Inc revenue
Head to head: CNSY vs INBSBMRA vs INBSINBS vs MCTAICCM vs INBS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies